Joint Appointment in Oncology; Joint Appointment in Urology
Obstetrics & Gynecology
Dr. Elizabeth A. Platz, MD
|
|
Give Review
Dr. Elizabeth A. Platz practices Obstetrics & Gynecology. She studied medicine at Medical University of South Carolina. Elizabeth Platz is also a published doctor. She has 101 publication published. The most recent publication is: Cross-sectional association between physical activity and serum testosterone levels in US men: results from NHANES 1999-2004.
Publications
- Effect of Finasteride on Serum Androstenedione and Risk of Prostate Cancer Within the Prostate Cancer Prevention Trial: Differential Effect on High- and Low-grade Dise...
- Circulating leukocyte telomere length and risk of overall and aggressive prostate cancer.
- Do environmental factors modify the genetic risk of prostate cancer?
- Polymorphisms influencing prostate-specific antigen concentration may bias genome-wide association studies on prostate cancer.
- Prospective Study of Seroreactivity to JC Virus T-Antigen and Risk of Colorectal Cancers and Adenomas.
- A Peripheral Circulating TH1 Cytokine Profile Is Inversely Associated with Prostate Cancer Risk in CLUE II.
- Do people know whether they are overweight? Concordance of self-reported, interviewer-observed, and measured body size.
- Prospective study of human herpesvirus type 8 serostatus and prostate cancer risk in the placebo arm of the Prostate Cancer Prevention Trial.
- Overexpression of α (1,6) fucosyltransferase Associated with aggressive prostate cancer.
- The Bacteroides fragilis toxin gene is prevalent in the colon mucosa of colorectal cancer patients.
- Association of variants in genes related to the immune response and obesity With BPH in CLUE II.
- Investigation of miR-21, miR-141, and miR-221 expression levels in prostate adenocarcinoma for Associated risk of recurrence after radical prostatectomy.
- Trajectory of overall health from self-report and factors contributing to health declines among cancer survivors.
- PTEN loss is Associated with upgrading of prostate cancer from biopsy to radical prostatectomy.
- Functional status declines among cancer survivors: Trajectory and contributing factors.
- Association of C-peptide and leptin With prostate cancer incidence in the Health Professionals Follow-up Study.
- GSTP1 promoter methylation is Associated with recurrence in early stage prostate cancer.
- Body mass index at early adulthood, subsequent weight change and cancer incidence and mortality.
- A prospective study of obesity, and the incidence and progression of lower urinary tract symptoms.
- Statin Drug Use Is Not Associated with Prostate Cancer Risk in Men who are Regularly Screened.
- The association between circulating high-sensitivity C-reactive protein concentration and pathologic measures of colonic inflammation.
- Telomere length as a risk factor for hereditary prostate cancer.
- To Adjust or Not in Studies on Racial Differences in Hormone Concentrations? Depends on the Question!
- Plasma C-reactive protein, genetic risk score, and risk of common cancers in the Atherosclerosis Risk in Communities study.
- Associations between urinary soy isoflavonoids and two inflammatory markers in adults in the United States in 2005-2008.
- Androgenetic alopecia at various ages and prostate cancer risk in an equal-access multiethnic case-control series of veterans.
- Short- and long-term risk of colorectal adenoma recurrence among whites and blacks.
- Insulin-like Growth factors and insulin-like Growth factor-binding proteins and prostate cancer risk: results from the prostate cancer prevention trial.
- Racial/ethnic differences in serum sex steroid hormone concentrations in US adolescent males.
- Prediagnostic Circulating Sex Hormones Are Not Associated with Mortality for Men with Prostate Cancer.
- Immunohistochemical expression of minichromosome maintenance complex protein 2 predicts biochemical recurrence in prostate cancer: a tissue microarray and digital imag...
- Non-steroidal anti-inflammatory drug use and the risk of benign prostatic hyperplasia-related outcomes and nocturia in the Prostate, Lung, Colorectal, and Ovarian Canc...
- Prospective study of cytomegalovirus serostatus and prostate cancer risk in the Prostate Cancer Prevention Trial.
- Prostate-specific antigen concentration in young men: new estimates and review of the literature.
- Racial variation in umbilical cord blood sex steroid hormones and the insulin-like Growth factor axis in African-American and white female neonates.
- Association between plasma 25-OH vitamin D and testosterone levels in men.
- Glycated hemoglobin and cancer incidence and mortality in the atherosclerosis in communities (ARIC) study, 1990-2006.
- A Prospective Study of the Associations Between Treated Diabetes Mellitus and Cancer Outcomes.
- Opportunities for the primary prevention of colorectal cancer in the United States.
- Repeat polymorphisms in estrogen metabolism genes and prostate cancer risk: results from the Prostate Cancer Prevention Trial.
- Increased gene copy number of ERG on chromosome 21 but not TMPRSS2-ERG fusion predicts outcome in prostatic adenocarcinomas.
- Immunohistochemistry for ERG Expression as a Surrogate for TMPRSS2-ERG Fusion Detection in Prostatic Adenocarcinomas.
- Body fatness and sex steroid hormone concentrations in US men: results from NHANES III.
- Serum estrogen levels and prostate cancer risk in the prostate cancer prevention trial: a nested case-control study.
- Body fat distribution, weight change during adulthood, and thyroid cancer risk in the NIH-AARP diet and health study.
- Comparison of Standard Methods for Assessing Dietary Intake of Benzo[a]pyrene.
- Cigarette smoking and prostate cancer recurrence after prostatectomy.
- Racial variation in umbilical cord blood leptin concentration in male babies.
- Weight gain is Associated with an increased risk of prostate cancer recurrence after prostatectomy in the PSA era.
- Association of statin use With pathological tumor characteristics and prostate cancer recurrence after surgery.
- Serum lycopene concentration and prostate cancer risk: results from the Prostate Cancer Prevention Trial.
- Association of serum α-tocopherol With sex steroid hormones and interactions With smoking: implications for prostate cancer risk.
- The prevalence of low sex steroid hormone concentrations in men in the Third National Health and Nutrition Examination Survey (NHANES III).
- Obesity and thyroid cancer risk among U.S. men and women: a pooled analysis of five prospective studies.
- Prostate cancer predisPosition loci and risk of metastatic disease and prostate cancer recurrence.
- Plasma insulin-like growth factor 1 is positively Associated with low-grade prostate cancer in the Health Professionals Follow-up Study 1993-2004.
- Minimal detection bias in the inverse association between statin drug use and advanced prostate cancer risk: A simulation study.
- Decreased expression of Cyr61 is Associated with prostate cancer recurrence after surgical treatment.
- Transition of a clinical trial into translational research: the prostate cancer prevention trial experience.
- Reduced risk of prostate cancer in U.S. Men With AIDS.
- Sexually transmitted diseases among users of erectile dysfunction drugs.
- Prostate cancer and PSA among statin users in the Finnish prostate cancer screening trial.
- Association between C-peptide concentration and prostate cancer incidence in the CLUE II cohort study.
- Prediction of mortality after radical prostatectomy by Charlson comorbidity index.
- Diet, supplement use, and prostate cancer risk: results from the prostate cancer prevention trial.
- Statin medication use and the risk of biochemical recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) Database.
- Is prostate cancer prevention With selenium all in the genes?
- Extracellular matrix Associated protein CYR61 is linked to prostate cancer development.
- Sex steroid hormone concentrations and risk of death in US men.
- Finasteride modifies the relation between serum C-peptide and prostate cancer risk: results from the Prostate Cancer Prevention Trial.
- Human papillomavirus types 16, 18, and 31 serostatus and prostate cancer risk in the Prostate Cancer Prevention Trial.
- Coumaphos exposure and incident cancer among male participants in the Agricultural Health Study (AHS).
- A randomized trial on folic acid supplementation and risk of recurrent colorectal adenoma.
- Men With low serum cholesterol have a lower risk of high-grade prostate cancer in the placebo arm of the prostate cancer prevention trial.
- Prospective study of Trichomonas vaginalis infection and prostate cancer incidence and mortality: Physicians' Health Study.
- Endogenous sex steroid hormones and measures of chronic kidney disease (CKD) in a nationally representative sample of men.
- Selenium, genetic variation, and prostate cancer risk: epidemiology reflects back on selenium and vitamin E cancer prevention trial.
- Association of IL10 and other immune response- and obesity-related genes With prostate cancer in CLUE II.
- Trichomonosis and subsequent risk of prostate cancer in the Prostate Cancer Prevention Trial.
- Prospective study of JC virus seroreactivity and the development of colorectal cancers and adenomas.
- Racial variation in sex steroid hormones and the insulin-like Growth factor axis in umbilical cord blood of male neonates.
- Re: Prostate-specific antigen: a misused and maligned prostate cancer biomarker.
- TMPRSS2-ERG gene fusions are infrequent in prostatic ductal adenocarcinomas.
- A simulation study of control sampling methods for nested case-control studies of genetic and molecular biomarkers and prostate cancer progression.
- Risk factors for hearing loss in US adults: data from the National Health and Nutrition Examination Survey, 1999 to 2002.
- Does statin use affect the risk of developing prostate cancer?
- Cadmium levels in urine and mortality among U.S. adults.
- Relationship of sex steroid hormones With bone mineral density (BMD) in a nationally representative sample of men.
- The influence of statin medications on prostate-specific antigen levels.
- Insulin-like Growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies.
- Association between plasma cholesterol and prostate cancer in the PSA era.
- C-reactive protein and colorectal cancer risk: a systematic review of prospective studies.
- Prevalence of hearing loss and differences by demographic characteristics among US adults: data from the National Health and Nutrition Examination Survey, 1999-2004.
- Re: The association between statins and cancer incidence in a veterans population.
- A community-based study of cigarette smoking behavior in relation to variation in three genes involved in dopamine metabolism: Catechol-O-methyltransferase (COMT), dop...
- Low testosterone and risk of premature death in older men: analytical and preanalytical issues in measuring circulating testosterone.
- A prospective study of lower urinary tract symptoms and erectile dysfunction.
- Inflammation and prostate cancer: a focus on infections.
- TNF polymorphisms and prostate cancer risk.
- Cross-sectional association between physical activity and serum testosterone levels in US men: results from NHANES 1999-2004.
Schools
Medical University of South Carolina
Procedures Preformed
- Sympathectomy
- Vaginal Birth After Cesarean (VBAC)
- Vaginal Delivery and VBAC
Conditions Treated
- Breech Position
- Encounters for High-Risk Pregnancies
- Encounters for Normal Pregnancies
- Gestational Diabetes
- View All
Doctors Specialties
- Obstetrics
- Gynecology
Accepted Insurances
Education
-
Medical University of South Carolina -
Medical University of South Carolina College of Medicine
Hospital
-
Johns Hopkins Hospital
Helpful Reviews
Similar Doctors
|
|
Dr. Patrick J. Marmion, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Duncan R. Neilson Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Virginia G. King, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jennifer Mahnke, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Axel K. Fuchs, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Craig E. Shambaugh, MD
This Doctor is OpenDoctor Recommended.
|